These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
745 related articles for article (PubMed ID: 16890590)
1. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590 [TBL] [Abstract][Full Text] [Related]
2. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features. Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117 [TBL] [Abstract][Full Text] [Related]
3. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype. Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856 [TBL] [Abstract][Full Text] [Related]
4. Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort. Malickova K; Lakatos PL; Bortlik M; Komarek V; Janatkova I; Lukas M Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):144-50. PubMed ID: 19927001 [TBL] [Abstract][Full Text] [Related]
5. Serologies in Crohn's disease: can we change the gray zone to black and white? Abreu MT Gastroenterology; 2006 Aug; 131(2):664-7. PubMed ID: 16890618 [No Abstract] [Full Text] [Related]
6. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice? Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069 [TBL] [Abstract][Full Text] [Related]
7. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007 [TBL] [Abstract][Full Text] [Related]
8. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718 [TBL] [Abstract][Full Text] [Related]
9. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543 [TBL] [Abstract][Full Text] [Related]
10. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B; Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104 [TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases. Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978 [TBL] [Abstract][Full Text] [Related]